<産業資料/調査レポートの題名> 2022年6月15日

抗がん剤上位10種類の世界市場:地域別(ヨーロッパ、アジア太平洋、LAMEA)


◆英文タイトル:Top 10 Cancer Drugs Market by Region (Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2018–2026

Chapter 1: Introduction

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings Of The Study
2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top Investment Pockets

3.3. Top Player Positioning, 2018
3.4. Porter’S Five Forces Analysis
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Rise In Incidence Of Cancer Across The Globe
3.5.1.2. Surge In Global Geriatric Population
3.5.1.3. Increase In Government Expenditure On Healthcare

3.5.2. Restraints

3.5.2.1. Adverse Effects Associated With The Use Cancer Drugs

3.5.3. Opportunities

3.5.3.1. High Growth Potential In Untapped Emerging Economies
3.5.3.2. Increase In Number Of Pipeline Drugs

3.5.4. Impact Analysis

Chapter 4: Cancer Drugs Market, By Region

4.1. Overview

4.1.1. Global Sales Of Top 50 Anticancer Drugs

4.2. Europe

4.2.1. Key Market Trends, Growth Factors, And Opportunities
4.2.2. Market Size And Forecast, By Country

4.2.2.1. Russia Cancer Drugs Market

4.2.2.1.1. Russia Sales Of Top 10 Cancer Drugs

4.2.2.2. Netherlands Cancer Drugs Market

4.2.2.2.1. Netherlands Sales Of Top 10 Cancer Drugs

4.2.2.3. Switzerland Cancer Drugs Market

4.2.2.3.1. Switzerland Sales Of Top 10 Cancer Drugs

4.2.2.4. Sweden Cancer Drugs Market

4.2.2.4.1. Sweden Sales Of Top 10 Cancer Drugs

4.2.2.5. Belgium Cancer Drugs Market

4.2.2.5.1. Belgium Sales Of Top 10 Cancer Drugs

4.2.2.6. Austria Cancer Drugs Market

4.2.2.6.1. Austria Sales Of Top 10 Cancer Drugs

4.2.2.7. Norway Cancer Drugs Market

4.2.2.7.1. Norway Sales Of Top 10 Cancer Drugs

4.2.2.8. Denmark Cancer Drugs Market

4.2.2.8.1. Denmark Sales Of Top 10 Cancer Drugs

4.2.2.9. Poland Cancer Drugs Market

4.2.2.9.1. Poland Sales Of Top 10 Cancer Drugs

4.2.2.10. Finland Cancer Drugs Market

4.2.2.10.1. Finland Sales Of Top 10 Cancer Drugs

4.2.2.11. Portugal Cancer Drugs Market

4.2.2.11.1. Portugal Sales Of Top 10 Cancer Drugs

4.2.2.12. Greece Cancer Drugs Market

4.2.2.12.1. Greece Sales Of Top 10 Cancer Drugs

4.2.2.13. Ireland Cancer Drugs Market

4.2.2.13.1. Ireland Sales Of Top 10 Cancer Drugs

4.2.2.14. Czech Republic Cancer Drugs Market

4.2.2.14.1. Czech Republic Sales Of Top 10 Cancer Drugs

4.2.2.15. Hungary Cancer Drugs Market

4.2.2.15.1. Hungary Sales Of Top 10 Cancer Drugs

4.2.2.16. Romania Cancer Drugs Market

4.2.2.16.1. Romania Sales Of Top 10 Cancer Drugs

4.2.2.17. Ukraine Cancer Drugs Market

4.2.2.17.1. Ukraine Sales Of Top 10 Cancer Drugs

4.3. Asia-Pacific

4.3.1. Key Market Trends, Growth Factors, And Opportunities
4.3.2. Market Size And Forecast, By Country

4.3.2.1. Taiwan Cancer Drugs Market

4.3.2.1.1. Taiwan Sales Of Top 10 Cancer Drugs

4.3.2.2. Indonesia Cancer Drugs Market

4.3.2.2.1. Indonesia Sales Of Top 10 Cancer Drugs

4.3.2.3. New Zealand Cancer Drugs Market

4.3.2.3.1. New Zealand Sales Of Top 10 Cancer Drugs

4.3.2.4. Singapore Cancer Drugs Market

4.3.2.4.1. Singapore Sales Of Top 10 Cancer Drugs

4.3.2.5. Malaysia Cancer Drugs Market

4.3.2.5.1. Malaysia Sales Of Top 10 Cancer Drugs

4.3.2.6. Vietnam Cancer Drugs Market

4.3.2.6.1. Vietnam Sales Of Top 10 Cancer Drugs

4.3.2.7. Myanmar Cancer Drugs Market

4.3.2.7.1. Myanmar Sales Of Top 10 Cancer Drugs

4.3.2.8. Sri Lanka Cancer Drugs Market

4.3.2.8.1. Sri Lanka Sales Of Top 10 Cancer Drugs

4.3.2.9. Macau Cancer Drugs Market

4.3.2.9.1. Macau Sales Of Top 10 Cancer Drugs

4.3.2.10. Nepal Cancer Drugs Market

4.3.2.10.1. Nepal Sales Of Top 10 Cancer Drugs

4.4. Lamea

4.4.1. Key Market Trends, Growth Factors, And Opportunities
4.4.2. Market Size And Forecast, By Country

4.4.2.1. Turkey Cancer Drugs Market

4.4.2.1.1. Turkey Sales Of Top 10 Cancer Drugs

4.4.2.2. Venezuela Cancer Drugs Market

4.4.2.2.1. Venezuela Sales Of Top 10 Cancer Drugs

4.4.2.3. Colombia Cancer Drugs Market

4.4.2.3.1. Colombia Sales Of Top 10 Cancer Drugs

4.4.2.4. Argentina Cancer Drugs Market

4.4.2.4.1. Argentina Sales Of Top 10 Cancer Drugs

4.4.2.5. Iran Cancer Drugs Market

4.4.2.5.1. Iran Sales Of Top 10 Cancer Drugs

4.4.2.6. Israel Cancer Drugs Market

4.4.2.6.1. Israel Sales Of Top 10 Cancer Drugs

4.4.2.7. Chile Cancer Drugs Market

4.4.2.7.1. Chile Sales Of Top 10 Cancer Drugs

4.4.2.8. Algeria Cancer Drugs Market

4.4.2.8.1. Algeria Sales Of Top 10 Cancer Drugs

4.4.2.9. Uae Cancer Drugs Market

4.4.2.9.1. Uae Sales Of Top 10 Cancer Drugs

4.4.2.10. Puerto Rico Cancer Drugs Market

4.4.2.10.1. Puerto Rico Sales Of Top 10 Cancer Drugs

4.4.2.11. Morocco Cancer Drugs Market

4.4.2.11.1. Morocco Sales Of Top 10 Cancer Drugs

4.4.2.12. Costa Rica Cancer Drugs Market

4.4.2.12.1. Costa Rica Sales Of Top 10 Cancer Drugs

4.4.2.13. Lebanon Cancer Drugs Market

4.4.2.13.1. Lebanon Sales Of Top 10 Cancer Drugs

Chapter 5: Company Profiles

5.1. Abbvie Inc.

5.1.1. Company Overview
5.1.2. Company Snapshot
5.1.3. Operating Business Segments
5.1.4. Product Portfolio
5.1.5. Business Performance
5.1.6. Key Strategic Moves And Developments

5.2. Astellas Pharma Inc.

5.2.1. Company Overview
5.2.2. Company Snapshot
5.2.3. Operating Business Segments
5.2.4. Product Portfolio
5.2.5. Business Performance

5.3. Astrazeneca Plc

5.3.1. Company Overview
5.3.2. Company Snapshot
5.3.3. Operating Business Segments
5.3.4. Product Portfolio
5.3.5. Business Performance
5.3.6. Key Strategic Moves And Developments

5.4. Bristol-Myers Squibb Company

5.4.1. Company Overview
5.4.2. Company Snapshot
5.4.3. Operating Business Segments
5.4.4. Product Portfolio
5.4.5. Business Performance
5.4.6. Key Strategic Moves And Developments

5.5. Celgene Corporation

5.5.1. Company Overview
5.5.2. Company Snapshot
5.5.3. Operating Business Segments
5.5.4. Product Portfolio
5.5.5. Business Performance

5.6. F. Hoffmann-La Roche Ltd.

5.6.1. Company Overview
5.6.2. Company Snapshot
5.6.3. Operating Business Segments
5.6.4. Product Portfolio
5.6.5. Business Performance
5.6.6. Key Strategic Moves And Developments

5.7. Johnson & Johnson (Janssen Global Services, Llc,)

5.7.1. Company Overview
5.7.2. Company Snapshot
5.7.3. Operating Business Segments
5.7.4. Product Portfolio
5.7.5. Business Performance

5.8. Merck & Co., Inc.

5.8.1. Company Overview
5.8.2. Company Snapshot
5.8.3. Operating Business Segments
5.8.4. Product Portfolio
5.8.5. Business Performance
5.8.6. Key Strategic Moves And Developments

5.9. Novartis Ag

5.9.1. Company Overview
5.9.2. Company Snapshot
5.9.3. Operating Business Segments
5.9.4. Product Portfolio
5.9.5. Business Performance

5.10. Pfizer Inc.

5.10.1. Company Overview
5.10.2. Company Snapshot
5.10.3. Operating Business Segments
5.10.4. Product Portfolio
5.10.5. Business Performance


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark